Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy
Science Advances · 05.09.2025 · 11 (36)
DOI: 10.1126/sciadv.adr8001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.09.2025. Verfasst von Fengxiang Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Immunotherapy, Doxorubicin, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cancer stem cells (CSCs) and myeloid-derived suppressor cells (MDSCs) contribute to chemoresistance and immunosuppression, constraining chemoimmunotherapy outcomes. Differentiation therapy, aiming to mature CSCs and MDSCs, shows great promise. However, its efficacy is hindered by limited accessibility in hypoxic deep tumor regions. Inspired by the apoptotic body (ApoBD)–mediated deep tumor penetration, we design a pulsatile sequential drug release system with a core-shell structure. The reversible acid-responsive shell protonates and swells in lysosomes to release doxorubicin, inducing lysosomal escape and cell apoptosis. In ApoBDs, it deprotonates and contracts to prevent excessive drug release. After deep penetration via ApoBDs, the hypoxia-responsive core releases all-trans retinoic acid to reverse CSCs and MDSCs, overcoming chemoresistance and modulating the immuno-microenvironment. This strategy targets the heterogeneous distribution of CSCs and MDSCs in solid tumors, enhancing chemo-intervention and immune checkpoint blockade therapy while presenting encouraging potential for cascade deep tumor penetration and differentiation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
- Guangdong Provincial Key Laboratory of Urology, Guangdong Engineering Research Center of Urinary Minimally invasive surgery Robot and Intelligent Equipment, Guangzhou Institute of Urology, The First Affiliated Hospital…
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, China.
- Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China.
ORCID-Profile: Fengxiang Liu, Shipeng Ning, Xia Wang, Mingxing Li, Zhonggui He, Kaiyuan Wang, Jin Sun
Zitieren
APA
Liu, F., Ning, S., Wang, X., Fan, X., Wan, B., Sun, F., Du, L., Shi, K., Zou, X., Zhu, R., Li, M., Shen, W., He, Z., Wang, K., & Sun, J. (2025). Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy. Science Advances, 11(36). https://doi.org/10.1126/sciadv.adr8001
Vancouver
Liu F, Ning S, Wang X, Fan X, Wan B, Sun F, et al. Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy. Science Advances. 2025;11(36). doi:10.1126/sciadv.adr8001
BibTeX
@article{Liu2025,
author = {Liu, Fengxiang and Ning, Shipeng and Wang, Xia and Fan, Xiaoyuan and Wan, Bin and Sun, Fei and Du, Lili and Shi, Kefan and Zou, Xinpeng and Zhu, Ruihong and Li, Mingxing and Shen, Wenwen and He, Zhonggui and Wang, Kaiyuan and Sun, Jin},
title = {Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {36},
doi = {10.1126/sciadv.adr8001}
}
EUVIMED